• +234 80 331 684 92
  • info@standardgenerics.com
  • No. 7, Agbor Close, Off Osolo Way, Ajao Estate, Lagos, Nigeria.

SYNTOSTAN INJECTION

Indications

  • Labor induction in pregnant women when natural labor does not start.
  • Augmentation of labor if contractions are insufficient to progress.
  • Management of postpartum hemorrhage (bleeding after childbirth).
  • Also used to stimulate contractions in cases of incomplete abortion or miscarriage Standard Generics.

Mechanism of Action


Safety: Contraindications & Warnings

Syntostan (oxytocin) is not appropriate in cases such as:

  • Cephalopelvic disproportion (when the baby’s size doesn’t fit the mother’s pelvis).
  • Abnormal fetal presentation, excess amniotic fluid, uterine hyperactivity, or risk of uterine rupture.
  • Previous caesarean section or uterine surgery.
  • Situations where vaginal delivery is contraindicated (e.g., placenta previa, cord prolapse, invasive cervical cancer).
  • Cases of fetal distress where delivery isn’t imminent.
  • Severe pre-eclampsia or other cardiovascular disorders, and certain other maternal conditions Standard Generics.

Precautions include:

  • Stopping the injection immediately if the uterus contracts excessively or if fetal distress occurs.
  • Avoid intramuscular use due to unpredictable absorption.
  • Monitor uterine activity, maternal blood pressure, heart rate, fluid balance, and neonatal status closely Standard Generics.

Known Interactions

  • Risk of severe hypertension when used 3–4 hours after vasoconstrictors under caudal block anesthesia.
  • Anesthesia agents such as cyclopropane may alter oxytocin’s cardiovascular effects and provoke unexpected hypotension or arrhythmias Standard Generics.

Potential Adverse Effects & Risks

Common/Serious Adverse Effects

  • Uterine hyperstimulation, potentially causing fetal heart rate deceleration.
  • Uterine rupture, especially with hypertonic uterine patterns.
  • Postpartum hemorrhage, uterine spasm or bleeding.
  • Water intoxication/hyponatremia, possibly leading to convulsions, coma, and death.
  • Cardiovascular events: maternal tachycardia/bradycardia, arrhythmias; neonatal bradycardia, premature ventricular contractions, hypertensive episodes.
  • Neonatal issues: jaundice, retinal hemorrhage, brain damage, seizures, low Apgar scores, even fetal death in severe cases.
  • Anaphylactic reactions, blood clotting disorders like afibrinogenemia or disseminated intravascular coagulation.
  • Other: headache, nausea, vomiting.

Many of these effects depend on dose and require intensive monitoring by skilled clinicians.


Summary Table

AspectDetails
Active IngredientSynthetic oxytocin (10 IU/mL in Syntostan)
PurposeInduce or augment labor, control postpartum bleeding
Key RisksUterine hyperstimulation, rupture, water intoxication, arrhythmias, neonatal harm
ContraindicationsFetal/maternal complications, prior uterine surgery, abnormal presentations
Monitoring NeedsUterine activity, fetal/maternal heart rate, BP, fluid status, neonatal condition
Use SettingHospital environment with skilled obstetric care

Bottom Line

Leave a Reply

Your email address will not be published. Required fields are marked *